178 related articles for article (PubMed ID: 32936421)
41. Magnolol Inhibits the Growth of Non-Small Cell Lung Cancer via Inhibiting Microtubule Polymerization.
Shen J; Ma H; Zhang T; Liu H; Yu L; Li G; Li H; Hu M
Cell Physiol Biochem; 2017; 42(5):1789-1801. PubMed ID: 28746938
[TBL] [Abstract][Full Text] [Related]
42. Honokiol confers immunogenicity by dictating calreticulin exposure, activating ER stress and inhibiting epithelial-to-mesenchymal transition.
Liu SH; Lee WJ; Lai DW; Wu SM; Liu CY; Tien HR; Chiu CS; Peng YC; Jan YJ; Chao TH; Pan HC; Sheu ML
Mol Oncol; 2015 Apr; 9(4):834-49. PubMed ID: 25619450
[TBL] [Abstract][Full Text] [Related]
43. Autophagosome accumulation-mediated ATP energy deprivation induced by penfluridol triggers nonapoptotic cell death of lung cancer via activating unfolded protein response.
Hung WY; Chang JH; Cheng Y; Cheng GZ; Huang HC; Hsiao M; Chung CL; Lee WJ; Chien MH
Cell Death Dis; 2019 Jul; 10(8):538. PubMed ID: 31308361
[TBL] [Abstract][Full Text] [Related]
44. β-Apopicropodophyllin functions as a radiosensitizer targeting ER stress in non-small cell lung cancer.
Kim JY; Cho JH; Kim EM; Shin HJ; Hwang SG; Song JY; Um HD; Park JK
Biomed Pharmacother; 2019 May; 113():108769. PubMed ID: 30870718
[TBL] [Abstract][Full Text] [Related]
45. Honokiol induces cell cycle arrest and apoptosis via inhibiting class I histone deacetylases in acute myeloid leukemia.
Li HY; Ye HG; Chen CQ; Yin LH; Wu JB; He LC; Gao SM
J Cell Biochem; 2015 Feb; 116(2):287-98. PubMed ID: 25187418
[TBL] [Abstract][Full Text] [Related]
46. Mitochondrial calcium overload contributes to cannabinoid-induced paraptosis in hormone-responsive breast cancer cells.
de la Harpe A; Beukes N; Frost C
Cell Prolif; 2024 May; ():e13650. PubMed ID: 38721827
[TBL] [Abstract][Full Text] [Related]
47. Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy.
Huang KJ; Kuo CH; Chen SH; Lin CY; Lee YR
J Cell Mol Med; 2018 Mar; 22(3):1894-1908. PubMed ID: 29363886
[TBL] [Abstract][Full Text] [Related]
48. Honokiol: a potent chemotherapy candidate for human colorectal carcinoma.
Chen F; Wang T; Wu YF; Gu Y; Xu XL; Zheng S; Hu X
World J Gastroenterol; 2004 Dec; 10(23):3459-63. PubMed ID: 15526365
[TBL] [Abstract][Full Text] [Related]
49. Honokiol inhibits epidermal growth factor receptor signaling and enhances the antitumor effects of epidermal growth factor receptor inhibitors.
Leeman-Neill RJ; Cai Q; Joyce SC; Thomas SM; Bhola NE; Neill DB; Arbiser JL; Grandis JR
Clin Cancer Res; 2010 May; 16(9):2571-9. PubMed ID: 20388852
[TBL] [Abstract][Full Text] [Related]
50. Honokiol regulates endoplasmic reticulum stress by promoting the activation of the sirtuin 1-mediated protein kinase B pathway and ameliorates high glucose/high fat-induced dysfunction in human umbilical vein endothelial cells.
Ye H; Meng Y
Endocr J; 2021 Aug; 68(8):981-992. PubMed ID: 33952780
[TBL] [Abstract][Full Text] [Related]
51. Honokiol induces autophagy of neuroblastoma cells through activating the PI3K/Akt/mTOR and endoplasmic reticular stress/ERK1/2 signaling pathways and suppressing cell migration.
Yeh PS; Wang W; Chang YA; Lin CJ; Wang JJ; Chen RM
Cancer Lett; 2016 Jan; 370(1):66-77. PubMed ID: 26454217
[TBL] [Abstract][Full Text] [Related]
52. Concurrently suppressing multidrug resistance and metastasis of breast cancer by co-delivery of paclitaxel and honokiol with pH-sensitive polymeric micelles.
Wang Z; Li X; Wang D; Zou Y; Qu X; He C; Deng Y; Jin Y; Zhou Y; Zhou Y; Liu Y
Acta Biomater; 2017 Oct; 62():144-156. PubMed ID: 28842335
[TBL] [Abstract][Full Text] [Related]
53. 6-Shogaol induces caspase-independent paraptosis in cancer cells via proteasomal inhibition.
Nedungadi D; Binoy A; Pandurangan N; Pal S; Nair BG; Mishra N
Exp Cell Res; 2018 Mar; 364(2):243-251. PubMed ID: 29462602
[TBL] [Abstract][Full Text] [Related]
54. Honokiol inhibits lung tumorigenesis through inhibition of mitochondrial function.
Pan J; Zhang Q; Liu Q; Komas SM; Kalyanaraman B; Lubet RA; Wang Y; You M
Cancer Prev Res (Phila); 2014 Nov; 7(11):1149-59. PubMed ID: 25245764
[TBL] [Abstract][Full Text] [Related]
55. Emodin induces apoptosis of lung cancer cells through ER stress and the TRIB3/NF-κB pathway.
Su J; Yan Y; Qu J; Xue X; Liu Z; Cai H
Oncol Rep; 2017 Mar; 37(3):1565-1572. PubMed ID: 28184934
[TBL] [Abstract][Full Text] [Related]
56. Honokiol induces apoptosis of lung squamous cell carcinoma by targeting FGF2-FGFR1 autocrine loop.
Cen M; Yao Y; Cui L; Yang G; Lu G; Fang L; Bao Z; Zhou J
Cancer Med; 2018 Dec; 7(12):6205-6218. PubMed ID: 30515999
[TBL] [Abstract][Full Text] [Related]
57. Synergistic antitumor effects of liposomal honokiol combined with adriamycin in breast cancer models.
Hou W; Chen L; Yang G; Zhou H; Jiang Q; Zhong Z; Hu J; Chen X; Wang X; Yuan Y; Tang M; Wen J; Wei Y
Phytother Res; 2008 Aug; 22(8):1125-32. PubMed ID: 18570244
[TBL] [Abstract][Full Text] [Related]
58. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis.
Nagalingam A; Arbiser JL; Bonner MY; Saxena NK; Sharma D
Breast Cancer Res; 2012 Feb; 14(1):R35. PubMed ID: 22353783
[TBL] [Abstract][Full Text] [Related]
59. Radiosensitization of NSCLC cells to X-rays and carbon ions by the CHK1/CHK2 inhibitor AZD7762, Honokiol and Tunicamycin.
Liu B; Chen W; Li H; Li F; Jin X; Li Q
Radiat Environ Biophys; 2020 Nov; 59(4):723-732. PubMed ID: 32857208
[TBL] [Abstract][Full Text] [Related]
60. Multifunctional effects of honokiol as an anti-inflammatory and anti-cancer drug in human oral squamous cancer cells and xenograft.
Cho JH; Jeon YJ; Park SM; Shin JC; Lee TH; Jung S; Park H; Ryu J; Chen H; Dong Z; Shim JH; Chae JI
Biomaterials; 2015; 53():274-84. PubMed ID: 25890726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
